Role of Yoga and Its Plausible Mechanism in the Mitigation of DNA Damage in Type-2 Diabetes: A Randomized Clinical Trial

Author(s):  
Rajesh G Nair ◽  
Mithila M Vasudev ◽  
Ramesh Mavathur

Abstract Background Although yoga is found to be beneficial in the management of type 2 diabetes (T2D), its mechanism of action is poorly understood. T2D is also known to be associated with increased oxidative stress (OS) and DNA damage. Purpose This study examines how yoga modulates OS-induced DNA damage and the efficiency of DNA repair in T2D conditions. Methods In this assessor-masked randomized clinical trial, T2D subjects (n = 61), aged (Mean ± SD, 50.3 ± 4.2) were randomly allocated into Yoga group (31) that received 10 weeks of yoga intervention and Control (30) with routine exercises. Molecular and biochemical assessments were done before and after the intervention period. Structural Equation Modeling using “R” was used for mediation analysis. Results At the end of the 10th week, Yoga group showed significant reduction in DNA damage indicators like Tail Moment (−5.88[95%CI: −10.47 to −1.30]; P = .013) and Olive Tail Moment (−2.93[95%CI: −4.87 to −1.00]; P < .01), oxidative DNA damage marker 8-OHdG (−60.39[95%CI: −92.55 to −28.23]; P < .001) and Fasting Blood Sugar (-22.58[95%CI: −44.33 to −0.83]; P = .042) compared to Control. OGG1 protein expression indicating DNA repair, improved significantly (17.55[95%CI:1.37 to 33.73]; P = .034) whereas Total Antioxidant Capacity did not (5.80[95%CI: -0.86 to 12.47]; P = 0.086). Mediation analysis indicated that improvements in oxidative DNA damage and DNA repair together played a major mediatory role (97.4%) in carrying the effect of yoga. Conclusion The beneficial effect of yoga on DNA damage in T2D subjects was found to be mediated by mitigation of oxidative DNA damage and enhancement of DNA repair. Clinical Trial information (www.ctri.nic.in) CTRI/2018/07/014825

Diabetes Care ◽  
2011 ◽  
Vol 34 (7) ◽  
pp. 1591-1594 ◽  
Author(s):  
M. G. Ramos-Zavala ◽  
M. Gonzalez-Ortiz ◽  
E. Martinez-Abundis ◽  
J. A. Robles-Cervantes ◽  
R. Gonzalez-Lopez ◽  
...  

2017 ◽  
Vol 14 (2-3) ◽  
pp. 301-310 ◽  
Author(s):  
Mitra Zarifkar ◽  
Sina Noshad ◽  
Mona Shahriari ◽  
Mohsen Afarideh ◽  
Elias Khajeh ◽  
...  

Aquichan ◽  
2021 ◽  
Vol 21 (1) ◽  
pp. 1-14
Author(s):  
Gerdane Celene Nunes Carvalho ◽  
Jose Claudio Garcia Lira Neto ◽  
Lívio César Cunha Nunes ◽  
Ana Maria Parente Garcia Alencar ◽  
Regina Lúcia Lino Marques ◽  
...  

Objective: To analyze the effectiveness of ginger in the reduction of the glycemic, lipid and anthropometric levels in people with Type 2 Diabetes Mellitus. Materials and method: A double-blind pilot study of the randomized clinical trial type, conducted between October 2017 and January 2018. The inclusion criteria were as follows: individuals with type 2 diabetes, aged from 18 to 80 years old, using oral antidiabetic drugs, and with glycated hemoglobin values between 7 % and 10 %. The participants were randomized and allocated in two different groups. In the experimental group, the participants used 1.2 g of ginger and, in the control group, 1.2 g of placebo. The primary outcome was the reduction in blood glucose. The reduction in the lipid and anthropometric levels was the secondary outcome. The intervention lasted four weeks. Results: A total of 21 participants were included in the study. The use of 1.2 g of ginger resulted in noticeable reductions in the anthropometric and lipid levels in 30 days of follow-up, but it did not reduce the glycemic levels. Conclusions: In this study, it was shown that ginger capsules, in doses of 1.2 g a day, can help to reduce anthropometric measures and lipid levels in the population under study; however, it had no effect on the glycemic levels.


Sign in / Sign up

Export Citation Format

Share Document